Overview

Vagus Nerve Stimulation Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

Vagus nerve is a crucial part of the autonomic nervous systems that controls involuntary body functions like heart rate. It passes from the abdomen to the lower part of the brain via chest and neck. Vagus nerve stimulation therapy is developed to prevent seizures by consistently sending mild electrical pulses through the vagus nerve to the brain. The VNS device is referred as the ‘brain pacemaker’ and it is placed on the chest wall under the skin. The vagus nerve is connected to the device using a wire. Vagus nerve stimulators are used for curing treatment resistant depression and intractable epilepsy.
The rising incidences of neurological disorders like epilepsy, obtaining efficient clinical outcomes using this technique are some crucial factors contributing to the vagus nerve stimulation market growth. Conversely, a lack of skilled healthcare professionals and step costs related with these devices shall restrain the market growth. On the other hand, rising research and development activities for expanding the range of applications of using neurostimulators shall provide substantial growth opportunities to the market. 

Market Segmentation:

By Product
•    Implantable VNS Devices         
•    External VNS Devices    
By Application
•    Depression
•    Epilepsy
•    Migraine
By Biomaterial
•    Ceramics 
•    Metallic
•    Polymerics
By End User
•    Hospitals
•    Ambulatory Surgical Centers  
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into product, application, biomaterial, end user and region. The product segment is fragmented into implantable VNS devices and external VNS devices. The external VNS devices are predicted to hold the largest vagus nerve stimulation market share as the process of fitting this device is minimally invasive, which is highly preferred by patients and is also a cheaper alternative than an implantable VNS device. The application segment is categorised into depression, epilepsy and migraine. The depression segment is predicted to lead the market as VNS devices are primarily used for treating treatment resistant depression. The biomaterial segment is divided into ceramic, metallic and polymerics. The end user segment is categorised into hospitals, ambulatory surgical centres and others. The hospital segment is anticipated to dominate the market owing to advancements in the hospital infrastructure, rise in the number of multispecialty hospitals and rising patient population across the world. 

Regional Analysis:

The North America region is predicted to dominate the market owing to a strong presence of key market players in the region. Furthermore, unprecedented advancements in the healthcare infrastructure in the region shall boost its market growth. Additionally, there has been a rising awareness amongst patients regarding neurological disorders and alternatives to treat them. 

Competitive Landscape:                            

Some of the crucial market players are Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, NeuroPace Inc. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global vagus nerve stimulation market by product, by application, by biomaterial, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
          1.4 Currency
          1.5 Limitations 
          1.6 Stakeholders     
2. Research Methodology 
          2.1 Research Data 
                 2.1.1 Secondary Data
                         2.1.1.1 Key Data from Secondary Sources
                 2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
         2.2 Market Size Estimation 
         2.3 Market Breakdown and Data Triangulation 
         2.4 Assumptions for the Study  
3. Executive Summary
         3.1 Market Outlook
         3.2 Segment Outlook
         3.3 Competitive Insights
4. Market Variables, Trends & Scope
         4.1 Market Lineage Outlook
         4.2 Penetration and Growth Prospect Mapping
         4.3 Industry Value Chain Analysis
         4.4 Cost Analysis Breakdown
         4.5 Technology Overview
         4.6 Regulatory Framework on Country Level
               4.6.1 Reimbursement Framework    
               4.6.2 Standards and Compliances
5. Market Overview
         5.1 Market Dynamics
               5.1.1 Market Driver Analysis         
               5.1.2 Market Restraint Analysis         
               5.1.3 Industry Challenges                   
6. Market Analysis tools                       
         6.1 Industry Analysis - Porter’s
                6.1.1 Supplier Power
                6.1.2 Buyer Power
                6.1.3 Substitution Threat
                6.1.4 Threat from new entrants
                6.1.5 Competitive Rivalry                  
         6.2 Pestel Analysis
                6.2.1 Political Landscape
                6.2.2 Environmental Landscape
                6.2.3 Social landscape
                6.2.4 Technology landscape
                6.2.5 Legal Landscape
7. Vagus Nerve Stimulations Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Implantable VNS Devices         
         7.2 External VNS Devices                        
8. Vagus Nerve Stimulations Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Depression
         8.2 Epilepsy
         8.3 Migraine         
9. Vagus Nerve Stimulations Market, By Biomaterial Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Ceramics 
         9.2 Metallic
         9.3 Polymerics
10. Vagus Nerve Stimulations Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         10.1 Hospitals
         10.2 Ambulatory Surgical Centers  
         10.3 Others     
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                11.2.1. U.S.
                11.2.2. Canada
                11.2.3. Mexico 
                11.2.4. Rest of North America
         11.3 Market Size (USD Mn) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Regional Market Trends
         12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.3.1. Brazil
                12.3.2. Venezuela
                12.3.3. Argentina
                12.3.4. Rest of Latin America
         12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                13.2.1. Germany
                13.2.2. U.K
                13.2.3. France
                13.2.4. Italy
                13.2.5 Switzerland
                13.2.6. Spain
                13.2.7. Russia
                13.2.8. Poland
                13.2.9. Rest of Western Europe
         13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         14.1 Introduction
         14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
             14.2.1 Japan
             14.2.2 China
             14.2.3 Singapore
             14.2.4 Korea         
             14.2.5 India
             14.2.6 Australia and New Zealand
             14.2.7 ASEAN
             14.2.8 Rest of Asia Pacific
         14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         15.1 Introduction
         15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                15.2.1 UAE
                15.2.2 South Africa
                15.2.3 Egypt
                15.2.4 Saudi Arabia
                15.2.5 Rest of MEA
         15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         16.1 Medtronic Plc.
              16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.1.2. Product Portfolio
              16.1.3. SWOT Analysis
              16.1.4. Financial Overview
              16.1.5. Strategic Overview
         16.2 ElectroCore LLC
              16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.2.2. Product Portfolio
              16.2.3. SWOT Analysis
              16.2.4. Financial Overview
              16.2.5. Strategic Overview
         16.3 LivaNova Plc.
              16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.3.2. Product Portfolio
              16.3.3. SWOT Analysis
              16.3.4. Financial Overview
              16.3.5. Strategic Overview
         16.4 Boston Scientific Corporation
              16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.4.2. Product Portfolio
              16.4.3. SWOT Analysis
              16.4.4. Financial Overview
              16.4.5. Strategic Overview
         16.5 Aleva Neurotherapeutics SA
              16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.5.2. Product Portfolio
              16.5.3. SWOT Analysis
              16.5.4. Financial Overview
              16.5.5. Strategic Overview
         16.6 BioControl Medical
              16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.6.2. Product Portfolio
              16.6.3. SWOT Analysis
              16.6.4. Financial Overview
              16.6.5. Strategic Overview
         16.7 Bioness Inc.
              16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.7.2. Product Portfolio
              16.7.3. SWOT Analysis
              16.7.4. Financial Overview
              16.7.5. Strategic Overview
         16.8 EnteroMedics Inc.
              16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.8.2. Product Portfolio
              16.8.3. SWOT Analysis
              16.8.4. Financial Overview
              16.8.5. Strategic Overview    
         16.9 Nevro Corporation
              16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.9.2. Product Portfolio
              16.9.3. SWOT Analysis
              16.9.4. Financial Overview
              16.9.5. Strategic Overview
         16.10 NeuroPace Inc.
              16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.10.2. Product Portfolio
              16.10.3. SWOT Analysis
              16.10.4. Financial Overview
              16.10.5. Strategic Overview
17. Impact of COVID-19
      17.1. Positive influence on the healthcare industry
      17.2. The financial disruption of the manufacturing sector
      17.3. Impact of COVID-19 on emerging companies
      17.4. Significant mandates in the healthcare regulations initiated by administrations
      17.5. The overall economic slowdown of the developing and developed nations
18. Competitive Intelligence and Competitive Matrix
      18.1 Competitive Intelligence
      18.2 Competitive Matrix
19. Major Deals and Strategic Alliances Analysis
      19.1 Joint ventures
      19.2 Mergers and acquisitions              
      19.3 Licensing and partnerships
      19.4 Technology Collaborations
      19.5 Strategic Divestments
      19.6 Market Entry Strategies                        
20. Relevant Case Studies and Latest News Updates
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics 

Tables

Figures